Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 421

    1.

    Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.

    Lange CM, Bojunga J, Hofmann WP, Wunder K, Mihm U, Zeuzem S, Sarrazin C.

    Hepatology. 2009 Dec;50(6):2001-2006.PMID: 19937695 [PubMed - as supplied by publisher]

    2.

    Do Differences in Pegylation of Interferon Alfa Matter?

    Zeuzem S.

    Gastroenterology. 2009 Nov 20. [Epub ahead of print] No abstract available. PMID: 19932662 [PubMed - as supplied by publisher]

    3.

    Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation.

    Peveling-Oberhag J, Zeuzem S, Hofmann WP.

    Med Microbiol Immunol. 2009 Nov 10. [Epub ahead of print]PMID: 19902246 [PubMed - as supplied by publisher]Related articles

    4.

    RNA-Binding Activity of Hepatitis C Virus NS4B: A Novel Target for Small Molecule Inhibitors.

    Welsch C, Zeuzem S.

    Gastroenterology. 2009 Oct 27. [Epub ahead of print] No abstract available. PMID: 19878748 [PubMed - as supplied by publisher]Related articles

    5.

    Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MS.

    Farnik H, El-Duweik J, Welsch C, Sarrazin C, Lötsch J, Zeuzem S, Geisslinger G, Schmidt H.

    J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 1;877(31):4001-6. Epub 2009 Oct 14.PMID: 19864192 [PubMed - in process]Related articles

    6.

    Real-time Elastography and Contrast-Enhanced Ultrasound for the Assessment of Thyroid Nodules.

    Friedrich-Rust M, Sperber A, Holzer K, Diener J, Grünwald F, Badenhoop K, Weber S, Kriener S, Herrmann E, Bechstein WO, Zeuzem S, Bojunga J.

    Exp Clin Endocrinol Diabetes. 2009 Oct 23. [Epub ahead of print]PMID: 19856256 [PubMed - as supplied by publisher]Related articles

    7.

    Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.

    Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Schlaphoff V, Dienes HP, Bock TC, Manns MP, Wedemeyer H; for HIDT-1 Study Group.

    Liver Int. 2009 Oct 15. [Epub ahead of print]PMID: 19840253 [PubMed - as supplied by publisher]Related articles

    8.

    Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.

    Friedrich-Rust M, Schwarz A, Ong M, Dries V, Schirmacher P, Herrmann E, Samaras P, Bojunga J, Bohle RM, Zeuzem S, Sarrazin C.

    Ultraschall Med. 2009 Oct;30(5):478-84. Epub 2009 Oct 7.PMID: 19813157 [PubMed - in process]Related articles

    9.

    Primary actinomycosis of the liver mimicking malignancy.

    Lange CM, Hofmann WP, Kriener S, Jacobi V, Welsch C, Just-Nuebling G, Zeuzem S.

    Z Gastroenterol. 2009 Oct;47(10):1062-4. Epub 2009 Oct 6.PMID: 19809957 [PubMed - in process]Related articles

    10.

    [Are there gender-related differences in the therapeutic management of patients suffering from inflammatory bowel disease? Subgroup analysis of a prospective multicentre online-based trial]

    Blumenstein I, Bock H, Zosel C, Dignass AU, Hartmann F, Zeuzem S, Stein JM, Schroeder O.

    Z Gastroenterol. 2009 Oct;47(10):1045-51. Epub 2009 Oct 6. German. PMID: 19809954 [PubMed - in process]Related articles

    11.

    Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic products.

    Waidmann O, Pleli T, Dvorak K, Baehr C, Mondorf U, Plotz G, Biondi RM, Zeuzem S, Piiper A.

    J Biol Chem. 2009 Nov 20;284(47):32256-63. Epub 2009 Sep 29.PMID: 19801629 [PubMed - in process]Related articles

    12.

    Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.

    Susser S, Welsch C, Wang Y, Zettler M, Domingues FS, Karey U, Hughes E, Ralston R, Tong X, Herrmann E, Zeuzem S, Sarrazin C.

    Hepatology. 2009 Dec;50(6):1709-1718.PMID: 19787809 [PubMed - as supplied by publisher]Related articles

    13.

    Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment.

    Lukasiewicz E, Gorfine M, Freedman LS, Pawlotsky JM, Schalm SW, Ferrari C, Zeuzem S, Neumann AU; for the DITTO-HCV Study Group.

    J Viral Hepat. 2009 Sep 25. [Epub ahead of print]PMID: 19780947 [PubMed - as supplied by publisher]Related articles

    14.

    Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome.

    Mihm U, Hofmann WP, Welsch C, Polta A, Lengauer T, Zeuzem S, Sarrazin C, Herrmann E.

    J Viral Hepat. 2009 Sep 15. [Epub ahead of print]PMID: 19758279 [PubMed - as supplied by publisher]Related articles

    15.

    Factors that Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa.

    Buster EH, Hansen BE, Lau GK, Piratvisuth T, Zeuzem S, Steyerberg EW, Janssen HL.

    Gastroenterology. 2009 Sep 6. [Epub ahead of print]PMID: 19737568 [PubMed - as supplied by publisher]Related articles

    16.

    Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1).

    Dettori R, Sonzogni S, Meyer L, Lopez-Garcia LA, Morrice NA, Zeuzem S, Engel M, Piiper A, Neimanis S, Frödin M, Biondi RM.

    J Biol Chem. 2009 Oct 30;284(44):30318-27. Epub 2009 Sep 1.PMID: 19723632 [PubMed - in process]Related articles

    17.

    Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.

    Hindie V, Stroba A, Zhang H, Lopez-Garcia LA, Idrissova L, Zeuzem S, Hirschberg D, Schaeffer F, Jørgensen TJ, Engel M, Alzari PM, Biondi RM.

    Nat Chem Biol. 2009 Oct;5(10):758-64. Epub 2009 Aug 30.PMID: 19718043 [PubMed - indexed for MEDLINE]Related articles

    18.

    Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

    Friedrich-Rust M, Wunder K, Kriener S, Sotoudeh F, Richter S, Bojunga J, Herrmann E, Poynard T, Dietrich CF, Vermehren J, Zeuzem S, Sarrazin C.

    Radiology. 2009 Aug;252(2):595-604.PMID: 19703889 [PubMed - indexed for MEDLINE]Related articles

    19.

    Forewarned is forearmed.

    Zeuzem S.

    J Hepatol. 2009 Oct;51(4):626-7. Epub 2009 Jul 2. No abstract available. PMID: 19660821 [PubMed - in process]Related articles

    20.

    Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C.

    Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U.

    J Viral Hepat. 2009 Jul 28. [Epub ahead of print]PMID: 19656290 [PubMed - as supplied by publisher]Related articles

    21.

    [Small bowel diverticula - unknown disease]

    Albert JG, Lübbert C, Surow A, Zeuzem S.

    Z Gastroenterol. 2009 Jul;47(7):674-81. Epub 2009 Jul 15. Review. German. PMID: 19606411 [PubMed - indexed for MEDLINE]Related articles

    22.

    Assessment of Liver Fibrosis and Steatosis in PBC With FibroScan, MRI, MR-spectroscopy, and Serum Markers.

    Friedrich-Rust M, Müller C, Winckler A, Kriener S, Herrmann E, Holtmeier J, Poynard T, Vogl TJ, Zeuzem S, Hammerstingl R, Sarrazin C.

    J Clin Gastroenterol. 2009 Jul 2. [Epub ahead of print]PMID: 19581812 [PubMed - as supplied by publisher]Related articles

    23.

    Rapid decrease of wild-type hepatitis C virus on telaprevir treatment.

    Adiwijaya BS, Hare B, Caron PR, Randle JC, Neumann AU, Reesink HW, Zeuzem S, Herrmann E.

    Antivir Ther. 2009;14(4):591-5.PMID: 19578245 [PubMed - indexed for MEDLINE]Related articles

    24.

    Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.

    Berg T, Weich V, Teuber G, Klinker H, Möller B, Rasenack J, Hinrichsen H, Gerlach T, Spengler U, Buggisch P, Balk H, Zankel M, Neumann K, Sarrazin C, Zeuzem S.

    Hepatology. 2009 Aug;50(2):369-77.PMID: 19575366 [PubMed - indexed for MEDLINE]Related articles

    25.

    Occludin a new HCV entry factor: is the list of essential hepatitis C virus receptors complete?

    Kronenberger B, Zeuzem S.

    Gastroenterology. 2009 Aug;137(2):727-8. Epub 2009 Jun 27. No abstract available. PMID: 19563843 [PubMed]Related articles

    26.

    Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.

    Wedemeyer H, Schuller E, Schlaphoff V, Stauber RE, Wiegand J, Schiefke I, Firbas C, Jilma B, Thursz M, Zeuzem S, Hofmann WP, Hinrichsen H, Tauber E, Manns MP, Klade CS.

    Vaccine. 2009 Aug 13;27(37):5142-51. Epub 2009 Jun 24.PMID: 19559112 [PubMed - indexed for MEDLINE]Related articles

    27.

    The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.

    Deterding K, Wiegand J, Grüner N, Hahn A, Jäckel E, Jung MC, Buggisch P, Galle P, Berg T, Hinrichsen H, Potthoff A, Zeuzem S, Cornberg M, Manns M, Wedemeyer H.

    Z Gastroenterol. 2009 Jun;47(6):531-40. Epub 2009 Jun 16.PMID: 19533544 [PubMed - indexed for MEDLINE]Related articles

    28.

    [The state of health care and health care paths in inflammatory bowel disease (Crohn's disease and ulcerative colitis)]

    Preiss JC, Blumenstein I, Zeuzem S, Zeitz M.

    Z Gastroenterol. 2009 Jun;47(6):529-30. Epub 2009 Jun 16. German. No abstract available. PMID: 19533543 [PubMed - indexed for MEDLINE]Related articles

    29.

    Current and future treatment options for HCV.

    Kronenberger B, Zeuzem S.

    Ann Hepatol. 2009 Apr-Jun;8(2):103-12. Review.PMID: 19502651 [PubMed - indexed for MEDLINE]Related articles

    30.

    Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.

    Penna-Martinez M, Ramos-Lopez E, Stern J, Hinsch N, Hansmann ML, Selkinski I, Grünwald F, Vorländer C, Wahl RA, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K.

    Thyroid. 2009 Jun;19(6):623-8.PMID: 19499989 [PubMed - indexed for MEDLINE]Related articles

    31.

    Hepatitis C: new therapeutic strategies needed for advanced disease.

    Hofmann WP, Zeuzem S.

    Nat Rev Gastroenterol Hepatol. 2009 Jun;6(6):325-7. No abstract available. PMID: 19494822 [PubMed - indexed for MEDLINE]Related articles

    32.

    Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C.

    Neumann AU, Pianko S, Zeuzem S, Yoshida EM, Benhamou Y, Mishan M, McHutchison JG, Pulkstenis E, Mani Subramanian G.

    J Hepatol. 2009 Jul;51(1):21-8. Epub 2009 Mar 11.PMID: 19447518 [PubMed - indexed for MEDLINE]Related articles

    33.

    Management of hepatitis C virus genotype 2 or 3 infection: treatment optimization on the basis of virological response.

    Zeuzem S, Rizzetto M, Ferenci P, Shiffman ML.

    Antivir Ther. 2009;14(2):143-54. Review.PMID: 19430089 [PubMed - indexed for MEDLINE]Related articles

    34.

    Reproducibility and limitations of transient elastography.

    Friedrich-Rust M, Zeuzem S.

    Liver Int. 2009 May;29(5):619-20. No abstract available. PMID: 19413664 [PubMed - indexed for MEDLINE]Related articles

    35.

    Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

    Hézode C, Forestier N, Dusheiko G, Ferenci P, Pol S, Goeser T, Bronowicki JP, Bourlière M, Gharakhanian S, Bengtsson L, McNair L, George S, Kieffer T, Kwong A, Kauffman RS, Alam J, Pawlotsky JM, Zeuzem S; PROVE2 Study Team.

    N Engl J Med. 2009 Apr 30;360(18):1839-50.PMID: 19403903 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    [Magnetic resonance cholangiopancreatography (MRCP) from a radiological and gastroenterological perspective]

    Vogl TJ, Zeuzem S, Zangos S, Hammerstingl R.

    Dtsch Med Wochenschr. 2009 May;134(19):1011-4. Epub 2009 Apr 28. German. PMID: 19401971 [PubMed - indexed for MEDLINE]Related articles

    37.

    Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy.

    Zimmer V, Feiden W, Becker G, Zimmer A, Reith W, Raedle J, Lammert F, Zeuzem S, Hirano M, Menges M.

    Neurogastroenterol Motil. 2009 Jun;21(6):627-31. Epub 2009 Mar 12.PMID: 19368660 [PubMed - indexed for MEDLINE]Related articles

    38.

    Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

    Zeuzem S, Gane E, Liaw YF, Lim SG, DiBisceglie A, Buti M, Chutaputti A, Rasenack J, Hou J, O'Brien C, Nguyen TT, Jia J, Poynard T, Belanger B, Bao W, Naoumov NV.

    J Hepatol. 2009 Jul;51(1):11-20. Epub 2009 Feb 12.PMID: 19345439 [PubMed - indexed for MEDLINE]Related articles

    39.

    Advanced chronic hepatitis C: how to handle if you cannot halt?

    Hofmann WP, Zeuzem S.

    Hepatology. 2009 Apr;49(4):1385-7. No abstract available. PMID: 19330861 [PubMed]Related articles

    40.

    Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.

    Pachiadakis I, Chokshi S, Cooksley H, Farmakiotis D, Sarrazin C, Zeuzem S, Michalak TI, Naoumov NV.

    Clin Immunol. 2009 Jun;131(3):415-25. Epub 2009 Mar 20.PMID: 19303818 [PubMed - indexed for MEDLINE]Related articles

    41.

    Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients.

    Akoglu B, Kriener S, Martens S, Herrmann E, Hofmann WP, Milovic V, Zeuzem S, Faust D.

    Clin Exp Med. 2009 Dec;9(4):259-62. Epub 2009 Mar 19.PMID: 19296053 [PubMed - in process]Related articles

    42.

    Optimal therapy in genotype 1 patients.

    Farnik H, Mihm U, Zeuzem S.

    Liver Int. 2009 Jan;29 Suppl 1:23-30. Review.PMID: 19207963 [PubMed - indexed for MEDLINE]Related articles

    43.

    Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

    Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U.

    Eur J Public Health. 2009 Jun;19(3):245-53. Epub 2009 Feb 5. Review.PMID: 19196737 [PubMed - indexed for MEDLINE]Related articles

    44.

    Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis B.

    Mihm U, Chan HL, Zeuzem S, Chim AM, Hui AY, Wong VW, Sung JJ, Herrmann E.

    Antivir Ther. 2008;13(8):1029-37.PMID: 19195328 [PubMed - indexed for MEDLINE]Related articles

    45.

    An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome family.

    Meyer C, Brieger A, Plotz G, Weber N, Passmann S, Dingermann T, Zeuzem S, Trojan J, Marschalek R.

    Clin Cancer Res. 2009 Feb 1;15(3):762-9.PMID: 19188145 [PubMed - indexed for MEDLINE]Related articles

    46.

    Future treatment options for HCV: double, triple, what is the optimal combination?

    Kronenberger B, Zeuzem S.

    Best Pract Res Clin Gastroenterol. 2008;22(6):1123-36. Review.PMID: 19187871 [PubMed - indexed for MEDLINE]Related articles

    47.

    [Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients]

    von Wagner M, Zeuzem S.

    Dtsch Med Wochenschr. 2009 Feb;134(6):255-8. Epub 2009 Jan 29. Review. German. PMID: 19180418 [PubMed - indexed for MEDLINE]Related articles

    48.

    Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.

    Friedrich-Rust M, Theobald J, Zeuzem S, Bojunga J.

    J Viral Hepat. 2009 Mar;16(3):168-77. Epub 2008 Oct 17.PMID: 19175874 [PubMed - indexed for MEDLINE]Related articles

    49.

    An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.

    Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG.

    J Viral Hepat. 2009 Mar;16(3):178-86. Epub 2008 Oct 24.PMID: 19175870 [PubMed - indexed for MEDLINE]Related articles

    50.

    Treatment of chronic hepatitis C: anticipated impact of resistance in patients treated with protease inhibitors.

    Kronenberger B, Zeuzem S.

    Curr Gastroenterol Rep. 2009 Feb;11(1):15-21.PMID: 19166654 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...